The EVOLVE China Clinical Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 412 participants.

Also called NCT01966159

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 412 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01966159
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01966159. Randomized; single masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2014-07 (actual). Results posted on 2016-02-18.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The EVOLVE China Clinical Trial
Acronym
EVOLVE-CHINA
Intervention (Device)
SYNERGY Investigational Device
Intervention (Device)
PE Plus Investigational Device
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct01966159
Content hash
0f1585d887009815da7ce600750fe9c06f1211cdae4425f9538cc41ead37ce6b